The year in cardiology: cardiovascular prevention
█ Current opinion
Authors:
Kausik K. Ray1, Ulrich Laufs2, Francesco Cosentino3, Melvin D. Lobo4, Ulf Landmesser5,6
1Department of Primary Care and Public Health, Imperial Centre for Cardiovascular Disease Prevention, Imperial College London, Reynolds building, St Dunstan’s Road, London W68RP, UK;
2Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Liebigstrasse 20, 04103 Leipzig, Germany;
3Unit of Cardiology, Department of Medicine, Karolinska Institute and Karolinska University Hospital, SE 171 76, Stockholm, Sweden;
4Department of Clinical Pharmacology, Barts NIHR Biomedical Research Centre, William Harvey Research Institute, QMUL Charterhouse Square, London EC1M 6BQ, UK;
5Department of Cardiology, Charite University Medicine Berlin, Berlin, Germany;
6Berlin Institute of Health (BIH); German Center of Cardiovascular Research (DZHK); Partner Site Berlin, Berlin, Germany
Received 5 November 2019; revised 3 December 2019; editorial decision 10 December 2019; accepted 19 December 2019
Preamble
Advances in genomics, understanding of the effects of cumulative exposure and various environmental risk factors have moved us closer to better models of care focused at early risk assessment and treatment to prevent cardiovascular (CV) disease. We review relevant contributions in 2019 to the field of CV disease prevention, with a focus on epidemiology, lipids, diabetes, and hypertension.
ISSUE: CARDIOLOGIA HUNGARICA | 2020 | VOLUME 50, ISSUE 5
click here to read the full article |
click here to read the pdf |